The Company has come out previously, in its FY2015 Annual Report, stating that it wants to maintain gearing at 30-40%. My opinion is it would be unrealistic to expect the loans to be fully repaid. However, equity has obviously been written down by ~$1bn, increasing its gearing, so it certainly needs to repay part of the facilities which is why the banks have insisted on semi-annual amortisation and converted them from revolving loan facilities to term loans. Just noting the company paid $17.6m and $13.8m in dividends in FY15 and FY14 respectively. That was 20% of NPAT. Something to bear in mind for the Companies ability to retain cash (from no dividends) and pay down debt.
- Forums
- ASX - By Stock
- SGH
- Ann: FY16 Earnings Guidance-SGH.AX
Ann: FY16 Earnings Guidance-SGH.AX, page-59
-
-
- There are more pages in this discussion • 400 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online